Cargando…

Hematopoietic stem cell transplantation alters susceptibility to pulmonary hypertension in Bmpr2-deficient mice

Increasing evidence suggests that patients with pulmonary arterial hypertension (PAH) demonstrate abnormalities in the bone marrow (BM) and hematopoietic progenitor cells. In addition, PAH is associated with myeloproliferative diseases. We have previously demonstrated that low-dose lipopolysaccharid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crosby, Alexi, Toshner, Mark R., Southwood, Mark R., Soon, Elaine, Dunmore, Benjamin J., Groves, Emily, Moore, Stephen, Wright, Penny, Ottersbach, Katrin, Bennett, Cavan, Guerrero, Jose, Ghevaert, Cedric, Morrell, Nicholas W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144516/ https://www.ncbi.nlm.nih.gov/pubmed/30160594 http://dx.doi.org/10.1177/2045894018801642

Ejemplares similares

Targeting translational read-through of premature termination mutations in BMPR2 with PTC124 for pulmonary arterial hypertension
por: Long, Lu, et al.
Publicado: (2020)

The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations
por: Dunmore, Benjamin J., et al.
Publicado: (2013)

Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
por: Long, Lu, et al.
Publicado: (2015)

Transcript Analysis Reveals a Specific HOX Signature Associated with Positional Identity of Human Endothelial Cells
por: Toshner, Mark, et al.
Publicado: (2014)

The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension
por: Ormiston, Mark L., et al.
Publicado: (2015)

TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling
por: Hurst, Liam A., et al.
Publicado: (2017)

Generation and Culture of Blood Outgrowth Endothelial Cells from Human Peripheral Blood
por: Ormiston, Mark L., et al.
Publicado: (2015)

Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival
por: Schwiening, Max, et al.
Publicado: (2022)

Homozygous missense variant in BMPR1A resulting in BMPR signaling disruption and syndromic features
por: Russell, Bianca E., et al.
Publicado: (2019)

A BMPR2/YY1 Signaling Axis Is Required for Human Cytomegalovirus Latency in Undifferentiated Myeloid Cells
por: Poole, Emma, et al.
Publicado: (2021)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Novoyatleva, Tatyana, et al.
Publicado: (2021)

An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis
por: Ainscough, Alexander J., et al.
Publicado: (2022)

Functional Changes in Pulmonary Arterial Endothelial Cells Associated with BMPR2 Mutations
por: Wang, Hu, et al.
Publicado: (2014)

Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling
por: Pickworth, Josephine, et al.
Publicado: (2017)

Physiologic and molecular consequences of endothelial Bmpr2 mutation
por: Majka, Susan, et al.
Publicado: (2011)

BMPR2 Variants Underlie Nonsyndromic Oligodontia
por: Zheng, Jinglei, et al.
Publicado: (2023)

Caveolae protect endothelial cells from membrane rupture during increased cardiac output
por: Cheng, Jade P.X., et al.
Publicado: (2015)

Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertension
por: Soon, Elaine, et al.
Publicado: (2011)

BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis
por: Evans, Jonathan D W, et al.
Publicado: (2016)

Targeting HIF2α-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension
por: Macias, David, et al.
Publicado: (2021)

Distinct responses to hypoxia in subpopulations of distal pulmonary artery cells contribute to pulmonary vascular remodeling in emphysema
por: Howard, L. S., et al.
Publicado: (2012)

Expression of mutant BMPR-II in pulmonary endothelial cells promotes apoptosis and a release of factors that stimulate proliferation of pulmonary arterial smooth muscle cells
por: Yang, Xudong, et al.
Publicado: (2011)

BMPR2 Promoter Variants Effect Gene Expression in Pulmonary Arterial Hypertension Patients
por: Song, Jie, et al.
Publicado: (2020)

Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Novoyatleva, Tatyana, et al.
Publicado: (2022)

Mutation in BMPR2 Promoter: A ‘Second Hit’ for Manifestation of Pulmonary Arterial Hypertension?
por: Viales, Rebecca Rodríguez, et al.
Publicado: (2015)

Oxidative injury is a common consequence of BMPR2 mutations
por: Lane, Kirk L., et al.
Publicado: (2011)

BMPR2 expression is suppressed by signaling through the estrogen receptor
por: Austin, Eric D, et al.
Publicado: (2012)

Fetal liver Mll-AF4+ hematopoietic stem and progenitor cells respond directly to poly(I:C), but not to a single maternal immune activation
por: Malouf, Camille, et al.
Publicado: (2019)

PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension
por: Ali, Md Khadem, et al.
Publicado: (2023)

Signaling from the Sympathetic Nervous System Regulates Hematopoietic Stem Cell Emergence during Embryogenesis
por: Fitch, Simon R., et al.
Publicado: (2012)

A Study on BMPR-IB Genes of Bayanbulak Sheep
por: Zuo, Beiyao, et al.
Publicado: (2013)

BMPR2 spruces up the endothelium in pulmonary hypertension
por: Xiong, Jianhua
Publicado: (2015)

Novel Advances in Modifying BMPR2 Signaling in PAH
por: Dannewitz Prosseda, Svenja, et al.
Publicado: (2020)

BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series)
por: Frump, Andrea, et al.
Publicado: (2018)

A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension
por: Yang, Peiran, et al.
Publicado: (2019)

Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations
por: Pfarr, Nicole, et al.
Publicado: (2011)

Single-cell RNA sequencing reveals that BMPR2 mutation regulates right ventricular function via ID genes
por: Du, Mingxia, et al.
Publicado: (2022)

Mate-pair sequencing identifies a cryptic BMPR2 mutation in hereditary pulmonary arterial hypertension
por: Chalmers, Sarah J., et al.
Publicado: (2021)

Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension
por: Yang, Peiran, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qmtb6d4o0jd3ulbqvs65tqi9s0